10-Q Filing

IOVANCE BIOTHERAPEUTICS, INC. CIK: 1425205 Q2 2022

Filing Information

Form Type	10-Q
Accession Number	`0001558370-22-012263`
Period End Date	20220630
Filing Date	20220804
Fiscal Year	2022
Fiscal Period	Q2
XBRL Instance	iova-20220630x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 64 Income Statement 40 Cash Flow Statement 64 Stockholders Equity 32 Comprehensive Income 12

Balance Sheet 64 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$78.23M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$108.08M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$82.76M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$426.18M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$316.38M	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$7.13M	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$3.55M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$507.96M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$431.59M	USD	Point-in-time
Common stock, par or stated value per share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common stock, par or stated value per share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$101.15M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$100.94M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	157.80M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	157.00M	shares	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$68.98M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$70.84M	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$91.59M	USD	Point-in-time
Long-term investments	`LongTermInvestments`	-	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	157.00M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	157.80M	shares	Point-in-time
Restricted cash	`RestrictedCash`	$6.43M	USD	Point-in-time
Restricted cash	`RestrictedCash`	$6.08M	USD	Point-in-time
Restricted cash	`RestrictedCash`	$6.08M	USD	Point-in-time
Long-term assets	`OtherAssetsNoncurrent`	$1.78M	USD	Point-in-time
Long-term assets	`OtherAssetsNoncurrent`	$856.00K	USD	Point-in-time
Total Assets	`Assets`	$610.88M	USD	Point-in-time
Total Assets	`Assets`	$777.33M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$20.01M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$27.38M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$56.77M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$37.70M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$6.48M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$5.06M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$64.19M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$89.20M	USD	Point-in-time
Operating lease liabilities - noncurrent	`OperatingLeaseLiabilityNoncurrent`	$65.47M	USD	Point-in-time
Operating lease liabilities - noncurrent	`OperatingLeaseLiabilityNoncurrent`	$73.00M	USD	Point-in-time
Long-term note payable	`LongTermNotesPayable`	$1.00M	USD	Point-in-time
Long-term note payable	`LongTermNotesPayable`	$1.00M	USD	Point-in-time
Total Non-Current Liabilities	`LiabilitiesNoncurrent`	$74.00M	USD	Point-in-time
Total Non-Current Liabilities	`LiabilitiesNoncurrent`	$66.47M	USD	Point-in-time
Total Liabilities	`Liabilities`	$155.67M	USD	Point-in-time
Total Liabilities	`Liabilities`	$138.19M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.000041666 par value; 300,000,000 shares authorized, 157,800,581 and 157,004,742 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$7.00K	USD	Point-in-time
Common stock, $0.000041666 par value; 300,000,000 shares authorized, 157,800,581 and 157,004,742 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$7.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-601.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-2.70M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.79B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.84B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.17B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.36B	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$472.69M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$621.66M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$551.99M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$647.43M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$656.50M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$744.41M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$777.33M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$610.88M	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$118.07M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$141.71M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$62.12M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$73.41M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$26.33M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$49.74M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$19.31M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$38.93M	USD	2 Qtrs
Total costs and expenses	`OperatingExpenses`	$157.00M	USD	2 Qtrs
Total costs and expenses	`OperatingExpenses`	$81.43M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$99.73M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$191.45M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-191.45M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-99.73M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-157.00M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-81.43M	USD	1 Quarter
Interest income, net	`InvestmentIncomeInterest`	$385.00K	USD	1 Quarter
Interest income, net	`InvestmentIncomeInterest`	$75.00K	USD	1 Quarter
Interest income, net	`InvestmentIncomeInterest`	$491.00K	USD	2 Qtrs
Interest income, net	`InvestmentIncomeInterest`	$196.00K	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-81.35M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-190.96M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-156.80M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-99.35M	USD	1 Quarter
Net Loss Per Share of Common Stock, Basic	`EarningsPerShareBasic`	$-0.63	USD	1 Quarter
Net Loss Per Share of Common Stock, Basic	`EarningsPerShareBasic`	$-0.53	USD	1 Quarter
Net Loss Per Share of Common Stock, Basic	`EarningsPerShareBasic`	$-1.21	USD	2 Qtrs
Net Loss Per Share of Common Stock, Basic	`EarningsPerShareBasic`	$-1.04	USD	2 Qtrs
Net Loss Per Share of Common Stock, Diluted	`EarningsPerShareDiluted`	$-1.04	USD	2 Qtrs
Net Loss Per Share of Common Stock, Diluted	`EarningsPerShareDiluted`	$-0.63	USD	1 Quarter
Net Loss Per Share of Common Stock, Diluted	`EarningsPerShareDiluted`	$-0.53	USD	1 Quarter
Net Loss Per Share of Common Stock, Diluted	`EarningsPerShareDiluted`	$-1.21	USD	2 Qtrs
Weighted Average Shares of Common Stock Outstanding, Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	150.57M	shares	2 Qtrs
Weighted Average Shares of Common Stock Outstanding, Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	157.27M	shares	1 Quarter
Weighted Average Shares of Common Stock Outstanding, Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	153.75M	shares	1 Quarter
Weighted Average Shares of Common Stock Outstanding, Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	157.19M	shares	2 Qtrs
Weighted Average Shares of Common Stock Outstanding, Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	153.75M	shares	1 Quarter
Weighted Average Shares of Common Stock Outstanding, Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	157.19M	shares	2 Qtrs
Weighted Average Shares of Common Stock Outstanding, Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	157.27M	shares	1 Quarter
Weighted Average Shares of Common Stock Outstanding, Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	150.57M	shares	2 Qtrs

Cash Flow Statement 64 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-81.35M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-190.96M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-156.80M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-99.35M	USD	1 Quarter
Stock-based compensation expense	`ShareBasedCompensation`	$44.73M	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$31.36M	USD	2 Qtrs
Amortization of right of use asset	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$4.81M	USD	2 Qtrs
Amortization of right of use asset	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$6.18M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$738.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.04M	USD	2 Qtrs
Accretion (amortization) of discounts and premiums on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-995.00K	USD	2 Qtrs
Accretion (amortization) of discounts and premiums on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-3.86M	USD	2 Qtrs
Loss on write-off of fixed assets	`ImpairmentOfLongLivedAssetsHeldForUse`	$314.00K	USD	2 Qtrs
Loss on write-off of fixed assets	`ImpairmentOfLongLivedAssetsHeldForUse`	-	USD	2 Qtrs
Prepaid expenses, other assets and long-term assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.66M	USD	2 Qtrs
Prepaid expenses, other assets and long-term assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$3.04M	USD	2 Qtrs
Operating lease liabilities, net of tenant improvement allowance received	`IncreaseDecreaseInOperatingLeaseLiability`	$902.00K	USD	2 Qtrs
Operating lease liabilities, net of tenant improvement allowance received	`IncreaseDecreaseInOperatingLeaseLiability`	$-2.89M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$4.95M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$65.00K	USD	2 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$611.00K	USD	2 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-15.05M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-116.40M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-151.44M	USD	2 Qtrs
Maturities of investments	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$284.14M	USD	2 Qtrs
Maturities of investments	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$320.15M	USD	2 Qtrs
Purchase of investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$85.84M	USD	2 Qtrs
Purchase of investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$381.78M	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$20.32M	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$16.02M	USD	2 Qtrs
Net cash provided by / (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$182.28M	USD	2 Qtrs
Net cash provided by / (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-81.95M	USD	2 Qtrs
Tax payments related to shares withheld for vested restricted stock units	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	-	USD	2 Qtrs
Tax payments related to shares withheld for vested restricted stock units	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$2.65M	USD	2 Qtrs
Proceeds from the issuance of common stock upon purchase of employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans`	-	USD	2 Qtrs
Proceeds from the issuance of common stock upon purchase of employee stock purchase plan	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans`	$582.00K	USD	2 Qtrs
Proceeds from the issuance of common stock upon exercise of options	`ProceedsFromStockOptionsExercised`	$1.42M	USD	2 Qtrs
Proceeds from the issuance of common stock upon exercise of options	`ProceedsFromStockOptionsExercised`	$10.19M	USD	2 Qtrs
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$203.16M	USD	2 Qtrs
Proceeds from the issuance of debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	2 Qtrs
Proceeds from the issuance of debt	`ProceedsFromIssuanceOfLongTermDebt`	$1.00M	USD	2 Qtrs
Net cash (used in) / provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$214.35M	USD	2 Qtrs
Net cash (used in) / provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-650.00K	USD	2 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$30.19M	USD	2 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$15.99M	USD	2 Qtrs
Cash, Cash Equivalents and Restricted Cash Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$88.85M	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$84.31M	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$114.50M	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$72.85M	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$88.85M	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$84.31M	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$114.50M	USD	Point-in-time
Cash, Cash Equivalents and Restricted Cash End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$72.85M	USD	Point-in-time
Net unrealized (loss) gain on investments	`UnrealizedGainLossOnInvestments`	$14.00K	USD	2 Qtrs
Net unrealized (loss) gain on investments	`UnrealizedGainLossOnInvestments`	$-2.10M	USD	2 Qtrs
Acquisition of property and equipment included in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$6.47M	USD	2 Qtrs
Acquisition of property and equipment included in accounts payable and accrued expenses	`CapitalExpendituresIncurredButNotYetPaid`	$967.00K	USD	2 Qtrs
Conversion of convertible preferred stock to common stock	`ConversionOfStockAmountConverted1`	-	USD	2 Qtrs
Conversion of convertible preferred stock to common stock	`ConversionOfStockAmountConverted1`	$1.00K	USD	2 Qtrs
Lease liabilities arising from obtaining right-of-use asset from new leases	`Rightofuseassetobtainedinexchangeforoperatingleaseliabilityfromnewleases`	$553.00K	USD	2 Qtrs
Lease liabilities arising from obtaining right-of-use asset from new leases	`Rightofuseassetobtainedinexchangeforoperatingleaseliabilityfromnewleases`	-	USD	2 Qtrs
Lease liabilities arising from obtaining right-of-use asset from lease modifications	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityFromLeaseModifications`	$555.00K	USD	2 Qtrs
Lease liabilities arising from obtaining right-of-use asset from lease modifications	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityFromLeaseModifications`	$7.49M	USD	2 Qtrs

Stockholders Equity 32 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquity`	$472.69M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$621.66M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$551.99M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$647.43M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$656.50M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$744.41M	USD	Point-in-time
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$14.41M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$31.36M	USD	2 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$22.47M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$44.73M	USD	2 Qtrs
Common stock issued upon purchase of employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$970.00K	USD	2 Qtrs
Tax payments related to shares withheld for vested restricted stock units	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet`	$-2.65M	USD	1 Quarter
Tax payments related to shares withheld for vested restricted stock units	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet`	$-2.65M	USD	2 Qtrs
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$9.22M	USD	2 Qtrs
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.74M	USD	1 Quarter
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.42M	USD	2 Qtrs
Common stock sold in public offering, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$203.16M	USD	2 Qtrs
Common stock sold in public offering, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$160.27M	USD	1 Quarter
Unrealized (loss) gain on investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$14.00K	USD	2 Qtrs
Unrealized (loss) gain on investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-2.10M	USD	2 Qtrs
Unrealized (loss) gain on investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-63.00K	USD	1 Quarter
Unrealized (loss) gain on investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-354.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-81.35M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-190.96M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-156.80M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-99.35M	USD	1 Quarter
Ending Balance	`StockholdersEquity`	$472.69M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$621.66M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$551.99M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$647.43M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$656.50M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$744.41M	USD	Point-in-time

Comprehensive Income 12 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLoss`	$-81.35M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-190.96M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-156.80M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-99.35M	USD	1 Quarter
Unrealized (loss) gain on investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$14.00K	USD	2 Qtrs
Unrealized (loss) gain on investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-2.10M	USD	2 Qtrs
Unrealized (loss) gain on investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-63.00K	USD	1 Quarter
Unrealized (loss) gain on investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-354.00K	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-156.79M	USD	2 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-99.70M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-81.41M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-193.05M	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.